Planning Ahead, Planning Behind: In Some Ways We Were Better Prepared for COVID-19 Than Expected

This article is part of series in which OECD experts and thought leaders – from around the world and all parts of society – address the COVID-19 crisis, discussing and developing solutions now and for the future. It aims to foster the fruitful of exchange of expertise and perspectives across fields to help us rise to this critical challenge. Opinions expressed do not necessarily represent the views of the OECD.

We have been preparing for COVID-19 but just didn’t know it. While not explicitly designed for this pandemic, key healthcare advances like remote care, home care and pharmaceutical innovation now put our health ecosystem in the position of scaling solutions that would not have been possible otherwise. These advances also hold promise far beyond the current crisis as we look to the future of health and its role in economic and fiscal stability as the world’s population ages. Indeed, it’s both timely and perhaps ironically inauspicious that in the first quarter of the new decade – marking the launch of the UN/WHO Decade of Healthy Ageing – we are living with a pandemic which challenges the core goal for that effort: healthier longevity.

In three key areas, our health ecosystem has been evolving in a way that prepared us not just for COVID-19, but also for the decade’s long-term vision for the 2 billion of us who are over 60 in OECD’s “ageing societies”, where there are already more old than young as we live longer and experiences lower birth-rates.

First, a range of professionals in the health ecosystem are taking on new, important roles. Recent news stories have spotlighted the essential work of nurses, doctors, firemen and hospital workers, but another group is also stepping up and transforming their role: elder caregivers in the home. Indeed, the sad but real death rate of older Europeans in facilities combined with the desire to stay out of hospitals is dramatically increasing the thirst for “care at home” both regarding urgent COVID-19 and related needs as well as general elder care. Elder home care is a cottage industry barely 25 years old but now a core part of our USD 15 trillion Global Silver Economy. It is now global and evolving rapidly during this COVID-19 pandemic to perform essential central roles to oversee, manage and enable healthcare delivery. The result will be a home care service force that looks very different even mid-way through our Decade of Healthy Ageing, with new skills, competencies, education and training. As we come out of COVID-19, we should reflect on how society might benefit from the lessons of this crisis.

Second, remote care technologies, enabled by artificial intelligence, are moving to the frontlines of monitoring, detection, diagnosis and even treatment. To date, technological advances in remote care have largely been a “nice-to-have” add-on for support and data management within our existing hospital infrastructure. COVID-19 changes this dynamic. When we all want to avoid physically being in a hospital, these technological tools can go right into our home and communities, literally becoming the new standard of care. Telehealth and telemedicine are in greater use today – reportedly advancing 10 years in just one week , as a consequence of COVID-19. And remote care will continue to expand across the Decade of Healthy Ageing, saving lives and bending the health spending curve. Its use in the current context would have been impossible without the advances of the last decade, thus unwittingly preparing us for today’s crisis.

Third, we – across the political spectrum – appreciate, welcome and demand private-sector innovation with greater momentum. As we fight COVID-19, new biomedical therapies, vaccines, and health technologies are essential – and critical for the social and economic health of ageing societies in OECD countries. We are now seeing innovation at incredible speed from actors that have swiftly reached into their existing portfolios to retrofit urgent scientific solutions and expand access. Pharmaceutical companies’ medicine chests, research pipeline, staff scientists and, perhaps most importantly, ability to scale have been in development for decades. For example, as scientists work to develop the COVID-19 vaccine, various treatments highlight the different but promising approaches. This “preparation” is invaluable for the immediate crisis and will be central to the goals of the Decade of Healthy Ageing.

Whilst these views may not be reflected in current COVID-19 media coverage, these three areas illustrate that our health systems were better prepared for this pandemic than otherwise assumed. Of course, we were not prepared explicitly for COVID-19, but leaders in elder home care, pharma, technology, health and financial services immediately put into action the fundamentals of their models, which can be scaled for both the current crisis and the health ecosystem in its aftermath.

Many have drawn parallels with World War II, when neither the United Kingdom nor the United States were fully prepared. OECD Secretary-General Gurría himself called for “joint actions to win the war”. Yet, allies were able to ramp up their efforts, mobilise their resources and amplify scale to eventually succeed. Out of this extraordinary mobilisation and scale came not only victory, but also advances and progress that multiplied exponentially in the post-war years. One might draw inspiration from this, and apply these lessons for our post-COVID-19 world.

Source: OECD Forum Network

Latest Developments

We keep our members and partners in touch with the most recent updates and opinions in the worldwide dialogue on population longevity and related issues.

Brazil Must Fight Antibiotic Resistance

The threat posed by antimicrobial resistance is urgent and spares no country - including Brazil. According to The Lancet, 63 deaths per 100,000 are associated with AMR in Brazil and Paraguay, a rate that exceeds the average for Latin America and the Caribbean. AMR-associated deaths in Brazil are second only to cardiovascular diseases and cancers.

We Missed 100 Million Adult Vaccines – Here’s How We Get Back on Track

Like other pandemics throughout human history, COVID-19 has caused profound changes that are still rippling through our societies, even as people are understandably eager to move on. In fact, these impacts are all the more dangerous when they are largely ignored or effectively invisible. The decline in adult vaccination may be one of the most significant, as a new report finds that ~100 million doses were missed in 2021 and 2022 alone – reversing global progress towards widespread adult immunisation as a new standard of care in a world of more old than young.

New Analysis Shows Lost Ground on Adult Immunisation During the Pandemic with 100 Million Doses Potentially Missed

New data shared today by GSK, in collaboration with the IQVIA Institute for Human Data Science and the Global Coalition on Aging (GCOA), estimate approximately 100 million fewer doses of some adult vaccines (excluding Covid-19 vaccines) were administered in 2021 and 2022 than anticipated, based on the global vaccination adoption trends observed from 2013 to 2020, compounding already low adoption rates pre-pandemic.

Going Beyond Applause: The Potential of Caregiving to Unlock Job Opportunities of the Future

Early in the COVID-19 pandemic, the role of caregivers – staff and family who provide care for older and dependent people to carry out activities such as eating or moving - catapulted to the front of our collective conscience. The daily applause for front-line care workers showed a high level of recognition for their incredible work and provided insight into how our health systems must change as our society ages. We need to continue to recognise caregivers as essential to our ageing society.

High-Level Forum on the Silver Economy 2023

Join us for the High-Level Forum on the Silver Economy 2023. Now in its fourth year, the Silver Economy Forum 2023, December 6 and 7, will explore aging at every stage of life, looking at the growing global Silver Economy through a multigenerational lens. Linking to the goals and aspirations of the UN Decade of Healthy Ageing, SEF 2023 will highlight key themes at the intersection of aging at every age, and the Silver Economy.

Global Coalition on Aging Workshop Calls on G7 Countries to Fund Pull Incentives to Spur Antibiotic Innovation

The Global Coalition on Aging, in partnership with JPMA, today announced the release of its workshop report on the AMR crisis facing G7 countries and the world, “The Value of Pull Incentives in Japan to Encourage Investment in Antibiotic Innovation to Solve the AMR Crisis.” If strong action is not taken to address AMR, we will lose the antibiotics we need to cure infections, which is likely to outpace cancer as a major cause of death, killing an estimated 10 million by 2050.